APOH
- 1 lab in 1 country
- Humans1
- Animals1
Effects
2Triglyceride secretion
upin human cells1
1 study
Triglyceride secretion
upin human cells1
APOH increases triglyceride secretion in human cells (p < 0.05).
“Finally, siRNA silencing of APOH in human Huh7 cells led to reduced TG secretion (two-sample t-test, p < 0.05).”
Cellsshown by knockdownhepatocytes
APOH plays a distinct role in lipid trait dysregulation and increased CVD risk
AHA Scientific Sessions 2025 abstract3 Nov 2025
Triglyceride
downin silico1
1 study
Triglyceride
downin silico1
APOH decreases triglyceride in silico (p < 5 x 10 −8).
“Mendelian randomization analysis suggested that genetically determined lower ApoH plasma levels causally decrease plasma TG levels (p < 5 x 10 −8 ).”
In silicoMendelian randomization
APOH plays a distinct role in lipid trait dysregulation and increased CVD risk
AHA Scientific Sessions 2025 abstract3 Nov 2025
Associations
2Low-density lipoprotein cholesterol
upin humans1
1 study
Low-density lipoprotein cholesterol
upin humans1
APOH is associated with low-density lipoprotein cholesterol in humans (p < 0.01).
“APOH C325G was associated with lower triglyceride (TG) levels and higher LDL-C, apoB, and Lp(a) levels (p < 0.01).”
Humanslaboratory analysis
APOH plays a distinct role in lipid trait dysregulation and increased CVD risk
AHA Scientific Sessions 2025 abstract3 Nov 2025
Triglyceride
downin humans1
1 study
Triglyceride
downin humans1
APOH is associated with triglyceride in humans (p < 0.01).
“APOH C325G was associated with lower triglyceride (TG) levels and higher LDL-C, apoB, and Lp(a) levels (p < 0.01).”
HumansPheWAS and laboratory analysis
APOH plays a distinct role in lipid trait dysregulation and increased CVD risk
AHA Scientific Sessions 2025 abstract3 Nov 2025